KRTAP2-5P

Across TCGA pan-cancer cohorts, KRTAP2-5P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated KRTAP2-5P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher KRTAP2-5P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KRTAP2-5P expression acts as an unfavorable survival marker, although some lineages such as READ show a favorable association.

THCA, STAD, and CESC are the cancer types where KRTAP2-5P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.723	0.983	<.001	90	view →
STAD	DFS	Tertile	II,III,IV	0.445	0.711	.002	45	view →
CESC	OS	Tertile	IV	0.121	0.591	.029	36	view →
KIRP	DFS	Tertile	All	0.218	0.771	.029	18	view →
BLCA	OS	Tertile	III,IV	0.205	0.475	.047	9	view →
PCPG	DFS	Tertile	All	0.161	0.819	.004	9	view →
BRCA	OS	Tertile	II,III,IV	0.907	0.958	.048	6	view →
READ	OS	Tertile	IV	1.000	0.633	.043	6	view →
UCEC	OS	Tertile	All	0.821	0.929	.028	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

KRTAP2-5P–THCA (OS)

Open the THCA breakdown →